New inhibitors of homoserine dehydrogenase from Paracoccidioides brasiliensis presenting antifungal activity.


Journal

Journal of molecular modeling
ISSN: 0948-5023
Titre abrégé: J Mol Model
Pays: Germany
ID NLM: 9806569

Informations de publication

Date de publication:
25 Oct 2019
Historique:
received: 08 05 2019
accepted: 30 09 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 4 4 2020
Statut: epublish

Résumé

Paracoccidioidomycosis (PCM) is a systemic mycosis caused by fungi of the genus Paracoccidioides spp., which mainly affects workers in rural regions of Latin America. Although the antifungal agents currently available for the treatment of PCM are effective in controlling the disease, many months are needed for healing, making the side effects and drug interactions relevant. In addition, conventional treatments are not able to control the sequelae left by PCM, even after the cure, justifying the search for new therapeutic options against PCM. In this context, the enzyme homoserine dehydrogenase of P. brasiliensis (PbHSD) was used to screen a library of natural products from the Zinc database using three different docking programs, i.e. Autodock, Molegro, and CLC Drugdiscovery Workbench. Three molecules (Zinc codes 2123137, 15967722, and 20611644) were better ranked than the homoserine substrate (HSE) and were used for in vitro trials of the minimum inhibitory concentration (MIC) and minimal fungicidal concentration (MCF). All three molecules presented a fungicidal profile with MICs/MCFs of 8, 32, and 128 μg mL

Identifiants

pubmed: 31654136
doi: 10.1007/s00894-019-4221-2
pii: 10.1007/s00894-019-4221-2
doi:

Substances chimiques

Antifungal Agents 0
Ligands 0
Homoserine Dehydrogenase EC 1.1.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325

Subventions

Organisme : Fundação Araucária
ID : 147/14 and 40/16
Organisme : CAPES
ID : 001
Organisme : CNPq
ID : 305960/2015-6

Références

Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30348661
Methods Mol Biol. 2012;819:305-23
pubmed: 22183545
Rev Soc Bras Med Trop. 2017 Sep-Oct;50(5):715-740
pubmed: 28746570
Nat Biotechnol. 2007 Feb;25(2):197-206
pubmed: 17287757
J Comput Chem. 2004 Aug;25(11):1400-15
pubmed: 15185334
Rev Inst Med Trop Sao Paulo. 1969 May-Jun;11(3):177-81
pubmed: 5824780
Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19:11-20
pubmed: 26465364
J Chem Inf Model. 2012 Jul 23;52(7):1757-68
pubmed: 22587354
Sci Rep. 2017 Dec 5;7(1):17014
pubmed: 29209049
Clin Microbiol Rev. 1999 Oct;12(4):501-17
pubmed: 10515900
Lancet Infect Dis. 2009 Dec;9(12):789-95
pubmed: 19926038
Med Clin North Am. 2001 Jan;85(1):149-85
pubmed: 11190350
Expert Opin Drug Deliv. 2007 Jul;4(4):403-16
pubmed: 17683253
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Mycoses. 2003 Sep;46(8):342-7
pubmed: 12950907
Molecules. 2014 Apr 24;19(4):5402-20
pubmed: 24879585
Bioorg Med Chem. 2004 Jul 15;12(14):3825-30
pubmed: 15210149
Open Microbiol J. 2017 Oct 31;11:224-282
pubmed: 29204222
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28652239
Antimicrob Agents Chemother. 2015 Aug;59(8):4982-9
pubmed: 26055382
Curr Protoc Immunol. 2015 Nov 02;111:A3.B.1-A3.B.3
pubmed: 26529666
Sci Rep. 2016 Aug 30;6:32213
pubmed: 27573798
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
pubmed: 11274893
Braz J Med Biol Res. 1998 May;31(5):615-23
pubmed: 9698765
J Comput Chem. 2011 Aug;32(11):2359-68
pubmed: 21541964
Biochim Biophys Acta. 2001 Jan 12;1544(1-2):28-41
pubmed: 11341914
Amino Acids. 2015 Feb;47(2):227-49
pubmed: 25408465
J Chem Inf Model. 2014 Jul 28;54(7):1951-62
pubmed: 24850022
Antimicrob Agents Chemother. 2001 Mar;45(3):922-6
pubmed: 11181381
Mycoses. 2000 Oct;43(9-10):325-32
pubmed: 11105535
Sci Rep. 2018 Apr 10;8(1):5749
pubmed: 29636528
J Pept Sci. 2018 Jan;24(1):null
pubmed: 29322651
Am J Med. 2012 Jan;125(1 Suppl):S3-13
pubmed: 22196207
Methods Mol Biol. 2015;1266:29-53
pubmed: 25560066
BMC Genomics. 2011 Jan 27;12:75
pubmed: 21272313
J Med Chem. 2011 Mar 24;54(6):1539-54
pubmed: 21344906
Int J Antimicrob Agents. 2016 Oct;48(4):428-30
pubmed: 27612594
J Fungi (Basel). 2017 Jan 03;3(1):null
pubmed: 29371520
J Med Chem. 2006 Jun 1;49(11):3315-21
pubmed: 16722650

Auteurs

Paulo Sérgio Alves Bueno (PSA)

Department of Technology, Universidade Estadual de Maringá, Campus Umuarama. Av. Ângelo Moreira da Fonseca, 1800, Umuarama, PR, 87506-370, Brazil.

Franciele Abigail Vilugron Rodrigues (FAV)

Department of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá, PR, Brazil.

Jessyka Lima Santos (JL)

São Carlos Institute of Chemistry, Universidade de São Paulo, São Carlos, SP, Brazil.

Fernanda Canduri (F)

São Carlos Institute of Chemistry, Universidade de São Paulo, São Carlos, SP, Brazil.

Débora Carina Biavatti (DC)

Department of Technology, Universidade Estadual de Maringá, Campus Umuarama. Av. Ângelo Moreira da Fonseca, 1800, Umuarama, PR, 87506-370, Brazil.

Arethusa Lobo Pimentel (AL)

Department of Technology, Universidade Estadual de Maringá, Campus Umuarama. Av. Ângelo Moreira da Fonseca, 1800, Umuarama, PR, 87506-370, Brazil.

Mariane Cristóvão Bagatin (MC)

Department of Chemistry, Universidade Estadual de Maringá, Maringá, PR, Brazil.

Érika Seki Kioshima (ÉS)

Department of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá, PR, Brazil.

Gisele de Freitas Gauze (G)

Department of Chemistry, Universidade Estadual de Maringá, Maringá, PR, Brazil.

Flavio Augusto Vicente Seixas (FAV)

Department of Technology, Universidade Estadual de Maringá, Campus Umuarama. Av. Ângelo Moreira da Fonseca, 1800, Umuarama, PR, 87506-370, Brazil. favseixas@uem.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH